.png){kind=icon}
-
Commercialization
市场访问和第IV阶段解决方案
-
Data & Technology Solutions
Data Capabilities 设计更美好的研究 Improve Study Recruitment 减少研究风险 Gain Operational Insights Ensure Data Quality Access Central Laboratory Information 授权您的数据 Maximize Product Access Transform Patient SafetyClinical Development
Clinical Pharmacology 早期临床/阶段IIA Phase IIb / III Services Clinical Data Management Analysis and Reporting 法规Services 第四阶段 Clinical Research Unit Virtual Tours Clinical-Biotech Decentralized Clinical Trials
-
Call Us
The Americas
+ 1.888.COVANCE（+1.888.268.2623） 1.609.452.4440Europe/Africa
+00.800.2682.2682 +44.1423.500888Asia/Pacific
+800.6568.3000 +65.6.5686588Global Office Locations
DU 145: Human Prostate Carcinoma
(The above parameters are from one study. For further information on this cell line and other parameters, including different strains, vendors, implant type and location and/or standards of care, please contact Covance.)
***请注意，小区线不销售，不可用的购物。***
Fill out our tumor models contact form to get started setting up your next preclinical study with us.
组型：Prostate
肿瘤线：Human
REF#367
Copyright © 2020 Covance Inc. All rights reserved.
Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.
Covance is a business segment of LabCorp, a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.